nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomustine—brain cancer—peripheral nervous system neoplasm	0.351	1	CtDrD
Lomustine—Alkylating Activity—Melphalan—peripheral nervous system neoplasm	0.316	0.556	CiPCiCtD
Lomustine—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.252	0.444	CiPCiCtD
Lomustine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00526	0.291	CbGbCtD
Lomustine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00489	0.271	CbGbCtD
Lomustine—STMN4—ganglion—peripheral nervous system neoplasm	0.00357	0.568	CbGeAlD
Lomustine—Neurologic reaction—Tretinoin—peripheral nervous system neoplasm	0.00251	0.0444	CcSEcCtD
Lomustine—Neurologic reaction—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.0444	CcSEcCtD
Lomustine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00225	0.124	CbGbCtD
Lomustine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.122	CbGbCtD
Lomustine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00206	0.114	CbGbCtD
Lomustine—Neurologic reaction—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.0336	CcSEcCtD
Lomustine—STMN4—trigeminal ganglion—peripheral nervous system neoplasm	0.00175	0.279	CbGeAlD
Lomustine—Pulmonary toxicity—Melphalan—peripheral nervous system neoplasm	0.00148	0.0261	CcSEcCtD
Lomustine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.0777	CbGbCtD
Lomustine—Optic atrophy—Vincristine—peripheral nervous system neoplasm	0.0013	0.0229	CcSEcCtD
Lomustine—Gastrointestinal toxicity—Etoposide—peripheral nervous system neoplasm	0.00123	0.0216	CcSEcCtD
Lomustine—Acute leukaemia—Topotecan—peripheral nervous system neoplasm	0.0012	0.0212	CcSEcCtD
Lomustine—Acute leukaemia—Melphalan—peripheral nervous system neoplasm	0.00118	0.0207	CcSEcCtD
Lomustine—Neurological symptom—Tretinoin—peripheral nervous system neoplasm	0.00113	0.0199	CcSEcCtD
Lomustine—Neurological symptom—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.0199	CcSEcCtD
Lomustine—Pulmonary toxicity—Cisplatin—peripheral nervous system neoplasm	0.000968	0.0171	CcSEcCtD
Lomustine—Neurological symptom—Alitretinoin—peripheral nervous system neoplasm	0.000854	0.0151	CcSEcCtD
Lomustine—Fibrosis—Cisplatin—peripheral nervous system neoplasm	0.000769	0.0136	CcSEcCtD
Lomustine—Acute leukaemia—Cisplatin—peripheral nervous system neoplasm	0.000769	0.0136	CcSEcCtD
Lomustine—STMN4—cerebellum—peripheral nervous system neoplasm	0.000765	0.122	CbGeAlD
Lomustine—Pulmonary fibrosis—Melphalan—peripheral nervous system neoplasm	0.000764	0.0135	CcSEcCtD
Lomustine—Myelosuppression—Topotecan—peripheral nervous system neoplasm	0.000732	0.0129	CcSEcCtD
Lomustine—Neurological symptom—Cisplatin—peripheral nervous system neoplasm	0.000728	0.0128	CcSEcCtD
Lomustine—Lung infiltration—Tretinoin—peripheral nervous system neoplasm	0.000726	0.0128	CcSEcCtD
Lomustine—Lung infiltration—Isotretinoin—peripheral nervous system neoplasm	0.000726	0.0128	CcSEcCtD
Lomustine—Myelosuppression—Melphalan—peripheral nervous system neoplasm	0.000716	0.0126	CcSEcCtD
Lomustine—Acute leukaemia—Etoposide—peripheral nervous system neoplasm	0.000704	0.0124	CcSEcCtD
Lomustine—Nephrotoxicity—Cisplatin—peripheral nervous system neoplasm	0.000691	0.0122	CcSEcCtD
Lomustine—Gastrointestinal toxicity—Epirubicin—peripheral nervous system neoplasm	0.000688	0.0121	CcSEcCtD
Lomustine—Gastrointestinal toxicity—Doxorubicin—peripheral nervous system neoplasm	0.000636	0.0112	CcSEcCtD
Lomustine—Blindness—Tretinoin—peripheral nervous system neoplasm	0.000615	0.0108	CcSEcCtD
Lomustine—Blindness—Isotretinoin—peripheral nervous system neoplasm	0.000615	0.0108	CcSEcCtD
Lomustine—Myelosuppression—Dactinomycin—peripheral nervous system neoplasm	0.000593	0.0105	CcSEcCtD
Lomustine—Lung infiltration—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.0097	CcSEcCtD
Lomustine—Myelosuppression—Vincristine—peripheral nervous system neoplasm	0.00053	0.00935	CcSEcCtD
Lomustine—Myelosuppression—Cisplatin—peripheral nervous system neoplasm	0.000469	0.00827	CcSEcCtD
Lomustine—Azotaemia—Vincristine—peripheral nervous system neoplasm	0.000466	0.00823	CcSEcCtD
Lomustine—Blindness—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.00822	CcSEcCtD
Lomustine—Pulmonary fibrosis—Etoposide—peripheral nervous system neoplasm	0.000458	0.00807	CcSEcCtD
Lomustine—Blindness—Vincristine—peripheral nervous system neoplasm	0.000449	0.00792	CcSEcCtD
Lomustine—Hepatotoxicity—Isotretinoin—peripheral nervous system neoplasm	0.000441	0.00777	CcSEcCtD
Lomustine—Hepatotoxicity—Tretinoin—peripheral nervous system neoplasm	0.000441	0.00777	CcSEcCtD
Lomustine—Myelosuppression—Etoposide—peripheral nervous system neoplasm	0.000429	0.00757	CcSEcCtD
Lomustine—Blindness—Cisplatin—peripheral nervous system neoplasm	0.000397	0.007	CcSEcCtD
Lomustine—Acute leukaemia—Epirubicin—peripheral nervous system neoplasm	0.000395	0.00697	CcSEcCtD
Lomustine—Contusion—Tretinoin—peripheral nervous system neoplasm	0.00039	0.00688	CcSEcCtD
Lomustine—Contusion—Isotretinoin—peripheral nervous system neoplasm	0.00039	0.00688	CcSEcCtD
Lomustine—Nephropathy toxic—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00675	CcSEcCtD
Lomustine—Acute leukaemia—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.00644	CcSEcCtD
Lomustine—Hepatotoxicity—Dactinomycin—peripheral nervous system neoplasm	0.00036	0.00635	CcSEcCtD
Lomustine—Dysarthria—Tretinoin—peripheral nervous system neoplasm	0.00036	0.00635	CcSEcCtD
Lomustine—Dysarthria—Isotretinoin—peripheral nervous system neoplasm	0.00036	0.00635	CcSEcCtD
Lomustine—Nephropathy toxic—Etoposide—peripheral nervous system neoplasm	0.000351	0.00618	CcSEcCtD
Lomustine—Hepatotoxicity—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00589	CcSEcCtD
Lomustine—Neoplasm—Topotecan—peripheral nervous system neoplasm	0.00031	0.00547	CcSEcCtD
Lomustine—Neoplasm—Melphalan—peripheral nervous system neoplasm	0.000304	0.00536	CcSEcCtD
Lomustine—Contusion—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.00521	CcSEcCtD
Lomustine—Hepatotoxicity—Cisplatin—peripheral nervous system neoplasm	0.000285	0.00502	CcSEcCtD
Lomustine—Dysarthria—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.00481	CcSEcCtD
Lomustine—Hepatotoxicity—Etoposide—peripheral nervous system neoplasm	0.000261	0.0046	CcSEcCtD
Lomustine—Visual disturbance—Tretinoin—peripheral nervous system neoplasm	0.000261	0.0046	CcSEcCtD
Lomustine—Visual disturbance—Isotretinoin—peripheral nervous system neoplasm	0.000261	0.0046	CcSEcCtD
Lomustine—Lethargy—Topotecan—peripheral nervous system neoplasm	0.000254	0.00448	CcSEcCtD
Lomustine—Lethargy—Tretinoin—peripheral nervous system neoplasm	0.000252	0.00445	CcSEcCtD
Lomustine—Lethargy—Isotretinoin—peripheral nervous system neoplasm	0.000252	0.00445	CcSEcCtD
Lomustine—Osteoarthritis—Isotretinoin—peripheral nervous system neoplasm	0.000247	0.00436	CcSEcCtD
Lomustine—Osteoarthritis—Tretinoin—peripheral nervous system neoplasm	0.000247	0.00436	CcSEcCtD
Lomustine—Myelosuppression—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00424	CcSEcCtD
Lomustine—Dysarthria—Cisplatin—peripheral nervous system neoplasm	0.000232	0.0041	CcSEcCtD
Lomustine—Myelosuppression—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00393	CcSEcCtD
Lomustine—Lethargy—Dactinomycin—peripheral nervous system neoplasm	0.000206	0.00363	CcSEcCtD
Lomustine—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.000204	0.00361	CcSEcCtD
Lomustine—Blindness—Epirubicin—peripheral nervous system neoplasm	0.000204	0.0036	CcSEcCtD
Lomustine—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.0002	0.00353	CcSEcCtD
Lomustine—Visual disturbance—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00348	CcSEcCtD
Lomustine—Lethargy—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00337	CcSEcCtD
Lomustine—Blindness—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00333	CcSEcCtD
Lomustine—Osteoarthritis—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.0033	CcSEcCtD
Lomustine—Renal failure—Tretinoin—peripheral nervous system neoplasm	0.000187	0.0033	CcSEcCtD
Lomustine—Renal failure—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.0033	CcSEcCtD
Lomustine—Stomatitis—Topotecan—peripheral nervous system neoplasm	0.000187	0.0033	CcSEcCtD
Lomustine—Stomatitis—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.00327	CcSEcCtD
Lomustine—Stomatitis—Tretinoin—peripheral nervous system neoplasm	0.000186	0.00327	CcSEcCtD
Lomustine—Stomatitis—Melphalan—peripheral nervous system neoplasm	0.000183	0.00323	CcSEcCtD
Lomustine—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.000173	0.00305	CcSEcCtD
Lomustine—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.000172	0.00304	CcSEcCtD
Lomustine—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.000172	0.00303	CcSEcCtD
Lomustine—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.000172	0.00303	CcSEcCtD
Lomustine—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000171	0.00301	CcSEcCtD
Lomustine—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000171	0.00301	CcSEcCtD
Lomustine—Ataxia—Vincristine—peripheral nervous system neoplasm	0.00017	0.00299	CcSEcCtD
Lomustine—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00017	0.00299	CcSEcCtD
Lomustine—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.000169	0.00298	CcSEcCtD
Lomustine—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.00292	CcSEcCtD
Lomustine—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.000165	0.0029	CcSEcCtD
Lomustine—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.000165	0.0029	CcSEcCtD
Lomustine—Alopecia—Topotecan—peripheral nervous system neoplasm	0.000152	0.00269	CcSEcCtD
Lomustine—Stomatitis—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.00268	CcSEcCtD
Lomustine—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.000151	0.00266	CcSEcCtD
Lomustine—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.000151	0.00266	CcSEcCtD
Lomustine—Alopecia—Melphalan—peripheral nervous system neoplasm	0.000149	0.00263	CcSEcCtD
Lomustine—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.000148	0.00261	CcSEcCtD
Lomustine—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.0025	CcSEcCtD
Lomustine—Stomatitis—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.00248	CcSEcCtD
Lomustine—Stomatitis—Vincristine—peripheral nervous system neoplasm	0.000136	0.00239	CcSEcCtD
Lomustine—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000134	0.00237	CcSEcCtD
Lomustine—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000131	0.00232	CcSEcCtD
Lomustine—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00231	CcSEcCtD
Lomustine—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.0023	CcSEcCtD
Lomustine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00013	0.0206	CbGeAlD
Lomustine—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.00228	CcSEcCtD
Lomustine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.0022	CcSEcCtD
Lomustine—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000123	0.00218	CcSEcCtD
Lomustine—Infection—Topotecan—peripheral nervous system neoplasm	0.000122	0.00214	CcSEcCtD
Lomustine—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.000121	0.00213	CcSEcCtD
Lomustine—Infection—Tretinoin—peripheral nervous system neoplasm	0.000121	0.00213	CcSEcCtD
Lomustine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.00213	CcSEcCtD
Lomustine—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00012	0.00212	CcSEcCtD
Lomustine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00012	0.00211	CcSEcCtD
Lomustine—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00012	0.00211	CcSEcCtD
Lomustine—Dysarthria—Epirubicin—peripheral nervous system neoplasm	0.000119	0.0021	CcSEcCtD
Lomustine—Infection—Melphalan—peripheral nervous system neoplasm	0.000119	0.0021	CcSEcCtD
Lomustine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000119	0.0021	CcSEcCtD
Lomustine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000119	0.0021	CcSEcCtD
Lomustine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000117	0.00207	CcSEcCtD
Lomustine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000117	0.00206	CcSEcCtD
Lomustine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000116	0.00204	CcSEcCtD
Lomustine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000116	0.00204	CcSEcCtD
Lomustine—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.00202	CcSEcCtD
Lomustine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000114	0.00201	CcSEcCtD
Lomustine—Renal failure—Etoposide—peripheral nervous system neoplasm	0.000111	0.00195	CcSEcCtD
Lomustine—Dysarthria—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00195	CcSEcCtD
Lomustine—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00011	0.00195	CcSEcCtD
Lomustine—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00011	0.00194	CcSEcCtD
Lomustine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000109	0.00192	CcSEcCtD
Lomustine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000106	0.00188	CcSEcCtD
Lomustine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00188	CcSEcCtD
Lomustine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000106	0.00186	CcSEcCtD
Lomustine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000106	0.00186	CcSEcCtD
Lomustine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000104	0.00184	CcSEcCtD
Lomustine—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.000102	0.0018	CcSEcCtD
Lomustine—Infection—Dactinomycin—peripheral nervous system neoplasm	9.86e-05	0.00174	CcSEcCtD
Lomustine—Alopecia—Cisplatin—peripheral nervous system neoplasm	9.75e-05	0.00172	CcSEcCtD
Lomustine—Leukopenia—Vincristine—peripheral nervous system neoplasm	9.73e-05	0.00172	CcSEcCtD
Lomustine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	9.72e-05	0.00171	CcSEcCtD
Lomustine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	9.68e-05	0.00171	CcSEcCtD
Lomustine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	9.6e-05	0.00169	CcSEcCtD
Lomustine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	9.6e-05	0.00169	CcSEcCtD
Lomustine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	9.46e-05	0.00167	CcSEcCtD
Lomustine—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.00167	CcSEcCtD
Lomustine—Infection—Alitretinoin—peripheral nervous system neoplasm	9.14e-05	0.00161	CcSEcCtD
Lomustine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	9.01e-05	0.00159	CcSEcCtD
Lomustine—Alopecia—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.00158	CcSEcCtD
Lomustine—Infection—Vincristine—peripheral nervous system neoplasm	8.81e-05	0.00155	CcSEcCtD
Lomustine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	8.77e-05	0.00155	CcSEcCtD
Lomustine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	8.68e-05	0.00153	CcSEcCtD
Lomustine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	8.63e-05	0.00152	CcSEcCtD
Lomustine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	8.6e-05	0.00152	CcSEcCtD
Lomustine—Anorexia—Vincristine—peripheral nervous system neoplasm	8.45e-05	0.00149	CcSEcCtD
Lomustine—Lethargy—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.00147	CcSEcCtD
Lomustine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.00144	CcSEcCtD
Lomustine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	8e-05	0.00141	CcSEcCtD
Lomustine—Leukopenia—Etoposide—peripheral nervous system neoplasm	7.88e-05	0.00139	CcSEcCtD
Lomustine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	7.85e-05	0.00138	CcSEcCtD
Lomustine—Infection—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.00137	CcSEcCtD
Lomustine—Vomiting—Topotecan—peripheral nervous system neoplasm	7.78e-05	0.00137	CcSEcCtD
Lomustine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.00136	CcSEcCtD
Lomustine—Vomiting—Tretinoin—peripheral nervous system neoplasm	7.72e-05	0.00136	CcSEcCtD
Lomustine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	7.72e-05	0.00136	CcSEcCtD
Lomustine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	7.71e-05	0.00136	CcSEcCtD
Lomustine—Ataxia—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.00136	CcSEcCtD
Lomustine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	7.68e-05	0.00135	CcSEcCtD
Lomustine—Vomiting—Melphalan—peripheral nervous system neoplasm	7.62e-05	0.00134	CcSEcCtD
Lomustine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.00134	CcSEcCtD
Lomustine—Anorexia—Cisplatin—peripheral nervous system neoplasm	7.47e-05	0.00132	CcSEcCtD
Lomustine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	7.27e-05	0.00128	CcSEcCtD
Lomustine—Nausea—Topotecan—peripheral nervous system neoplasm	7.27e-05	0.00128	CcSEcCtD
Lomustine—Nausea—Tretinoin—peripheral nervous system neoplasm	7.21e-05	0.00127	CcSEcCtD
Lomustine—Nausea—Isotretinoin—peripheral nervous system neoplasm	7.21e-05	0.00127	CcSEcCtD
Lomustine—Infection—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.00126	CcSEcCtD
Lomustine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.00126	CcSEcCtD
Lomustine—Nausea—Melphalan—peripheral nervous system neoplasm	7.12e-05	0.00126	CcSEcCtD
Lomustine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	7.03e-05	0.00124	CcSEcCtD
Lomustine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	7.01e-05	0.00124	CcSEcCtD
Lomustine—Anorexia—Etoposide—peripheral nervous system neoplasm	6.85e-05	0.00121	CcSEcCtD
Lomustine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	6.82e-05	0.0012	CcSEcCtD
Lomustine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.00119	CcSEcCtD
Lomustine—CYP2D6—cerebellum—peripheral nervous system neoplasm	6.39e-05	0.0102	CbGeAlD
Lomustine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.31e-05	0.00111	CcSEcCtD
Lomustine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.24e-05	0.0011	CcSEcCtD
Lomustine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.0011	CcSEcCtD
Lomustine—Renal failure—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.00109	CcSEcCtD
Lomustine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.2e-05	0.00109	CcSEcCtD
Lomustine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.00109	CcSEcCtD
Lomustine—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.89e-05	0.00104	CcSEcCtD
Lomustine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.85e-05	0.00103	CcSEcCtD
Lomustine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.00101	CcSEcCtD
Lomustine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.001	CcSEcCtD
Lomustine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.001	CcSEcCtD
Lomustine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.68e-05	0.001	CcSEcCtD
Lomustine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.001	CcSEcCtD
Lomustine—Vomiting—Vincristine—peripheral nervous system neoplasm	5.64e-05	0.000994	CcSEcCtD
Lomustine—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.47e-05	0.000964	CcSEcCtD
Lomustine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000963	CcSEcCtD
Lomustine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.00093	CcSEcCtD
Lomustine—Nausea—Vincristine—peripheral nervous system neoplasm	5.27e-05	0.000929	CcSEcCtD
Lomustine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000925	CcSEcCtD
Lomustine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000891	CcSEcCtD
Lomustine—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000883	CcSEcCtD
Lomustine—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.99e-05	0.000879	CcSEcCtD
Lomustine—Nausea—Cisplatin—peripheral nervous system neoplasm	4.66e-05	0.000821	CcSEcCtD
Lomustine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000817	CcSEcCtD
Lomustine—Vomiting—Etoposide—peripheral nervous system neoplasm	4.57e-05	0.000805	CcSEcCtD
Lomustine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.000779	CcSEcCtD
Lomustine—Nausea—Etoposide—peripheral nervous system neoplasm	4.27e-05	0.000753	CcSEcCtD
Lomustine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000721	CcSEcCtD
Lomustine—Infection—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000706	CcSEcCtD
Lomustine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000695	CcSEcCtD
Lomustine—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000677	CcSEcCtD
Lomustine—Infection—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000653	CcSEcCtD
Lomustine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000643	CcSEcCtD
Lomustine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000626	CcSEcCtD
Lomustine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000617	CcSEcCtD
Lomustine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000571	CcSEcCtD
Lomustine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000561	CcSEcCtD
Lomustine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000519	CcSEcCtD
Lomustine—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.56e-05	0.000452	CcSEcCtD
Lomustine—Nausea—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000422	CcSEcCtD
Lomustine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.37e-05	0.000418	CcSEcCtD
Lomustine—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.00039	CcSEcCtD
